ARID1A loss in cancer: Towards a mechanistic understanding
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference103 articles.
1. ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas;Allo;Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc,2014
2. The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers;Alver;Nature Communications,2017
3. The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation;Barker;The EMBO Journal,2001
4. Enhancer dysfunction in leukemia;Bhagwat;Blood,2018
5. Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers;Bitler;Nature Medicine,2015
Cited by 107 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Genome-Wide CRISPR Screen Identifies KEAP1 Perturbation as a Vulnerability of ARID1A-Deficient Cells;Cancers;2024-08-24
2. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches;Molecular Cancer;2024-07-25
3. ARID1A restrains EMT and stemness of ovarian cancer cells through the Hippo pathway;International Journal of Oncology;2024-06-14
4. Efficacy of immunotherapy in ARID1A-mutant solid tumors: a single-center retrospective study;Discover Oncology;2024-06-07
5. ARID1A loss promotes RNA editing of CDK13 in an ADAR1-dependent manner;BMC Biology;2024-06-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3